| Literature DB >> 34004552 |
Rafael Gonzalez Dos Santos1, Gabriel Silva Santos2, Natasha Alkass3, Tania Liana Chiesa4, Gabriel Ohana Azzini5, Lucas Furtado da Fonseca6, Antonio Fernando Dos Santos7, Bruno Lima Rodrigues8, Tomas Mosaner9, José Fábio Lana10.
Abstract
Orthobiologics continue to gain popularity in many areas of medical science, especially in the field of regenerative medicine. Platelet-rich plasma derivatives are orthobiologic tools of particular interest. These biologic products can be obtained via centrifugation of a patient's whole blood and the components can then be subsequently isolated, concentrated and ultimately administered into injured tissues, particularly in areas where standard healing is disrupted. The elevated concentration of platelets above the basal value enables accelerated growth of various tissues with minimal side effects. The application of autologous orthobiologics is a relatively new biotechnology undergoing expansion which continues to reveal optimistic results in the stimulation and enhanced healing of various sorts of tissue injuries. The local release of growth factors and cytokines contained in platelet alpha granules accelerates and ameliorates tissue repair processes, mimicking and supporting standard wound healing. This effect is greatly enhanced upon combination with the fibrinolytic system, which are essential for complete regeneration. Fibrinolytic reactions can dictate proper cellular recruitment of certain cell populations such as mesenchymal stem cells and other immunomodulatory agents. Additionally, these reactions also control proteolytic activity in areas of wound healing and regenerative processes of mesodermal tissues including bone, cartilage, and muscle, which makes it particularly valuable for musculoskeletal health, for instance. Although many investigations have demonstrated significant results with platelet-rich plasma derivatives, further studies are still warranted.Entities:
Keywords: Inflammation; Orthobiologics; Platelet-rich plasma; Regenerative medicine; Tissue healing
Mesh:
Substances:
Year: 2021 PMID: 34004552 DOI: 10.1016/j.cyto.2021.155560
Source DB: PubMed Journal: Cytokine ISSN: 1043-4666 Impact factor: 3.861